All data derived from the INTERGROWTH-21st multicentre study is the property of the Oxford Maternal and Perinatal Health Institute (OMPHI) of the Nuffield Department of Obstetrics and Gynaecology at the University of Oxford.
After the publication of the growth curves and the main papers related to the secondary objectives, the pooled data set will enter the public domain at a time to be determined by the steering committee. The anonymity of all study participants will be ensured. Analysis of the data is still under process, therefore any requests for access to data will be reviewed by the steering committee upon reasonable request for academic use only and within the limitations of the informed consent.
As per the INTERGROWTH-21st Study Protocol available below, any proposals for ancillary studies will be considered as long as a) they do not result in alterations to the main protocol and b) they do not impact adversely on subject recruitment and/or participation in the main study. All ancillary studies and/or additional data collection must be submitted to the executive committee (email@example.com) for written approval before implementation. A letter of intent must be submitted at the conceptual stage of the ancillary study. If approved by the executive committee, the local Principal Investigator(s) will be invited to submit a detailed proposal that should include the study’s rationale, objective, methodology, expected outcomes, and budget.